Clinical trial
Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa
NCT07708480 is registered in ClinicalTrials.gov with Hayat Abad Medical Complex, Peshawar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa
- Lead sponsor
- Hayat Abad Medical Complex, Peshawar
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 22, 2024
- Completion date
- May 22, 2025
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.